Form 8-K · Current report

Humana 8-K, filed Nov 6, 2026

Filed
CIK
0000049071
Accession no.
0000049071-26-000064
AI-generated summary

Summary

Humana reported third-quarter 2026 GAAP earnings per share of $1.33 and an adjusted loss per share of $0.70, while raising full-year 2026 adjusted EPS guidance to at least $9.50 from at least $9.00 and revising GAAP EPS guidance to at least $15.09 from at least $6.52. President and CEO Jim Rechtin said the company is delivering positive results for members and patients and increasingly driving financial and operating performance ahead of its plan.

Key points

  • 3Q26 Insurance segment GAAP benefit ratio was 93.7%, favorable to management's guidance of slightly above 94%.
  • Humana announced a joint venture with HPS Investment Partners (BlackRock) and CenterWell Senior Primary Care, replacing previous joint ventures with Welsh, Carson, Anderson & Stowe.
  • Year-to-date CenterWell Senior Primary Care patient growth was 146,800, or 30%.
  • Year-to-date Medicaid membership growth was 103,600, or 7%, largely driven by integrated Duals programs in Michigan, Illinois, and South Carolina.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

Items reported

  • 2.02Results of Operations and Financial Condition
  • 7.01Regulation FD Disclosure
  • 9.01Financial Statements and Exhibits

From the filing

Item 2.02 Results of Operations and Financial Condition. Item 7.01 Regulation FD Disclosure. Humana Inc. (the "Company") issued a press release this morning reporting financial results for the quarter ended September 30, 2026, and posted a detailed earnings release related to the same period to the Investor Relations portion of the Company’s website at www.humana.com. A copy of each release is attached hereto as Exhibit 99.1 and Exhibit 99.2, respectively, and each release is incorporated herein by reference. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Humana in Readster

Add Humana to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.